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Humanswithprimarybiliarycirrhosis (PBC),adisease
characterized by the destruction of small bile ducts,
exhibit signature autoantibodies against mitochon-
drial Pyruvate Dehydrogenase Complex E2 (PDC-E2)
that crossreact onto the homologous enzyme of
Novosphingobium aromaticivorans, an ubiquitous
alphaproteobacterium. Here, we show that infection
of mice with N. aromaticivorans induced signature
antibodies against microbial PDC-E2 and its mito-
chondrial counterpart but also triggered chronic T
cell-mediated autoimmunity against small bile ducts.
Disease induction required NKT cells, which specifi-
cally respond toN.aromaticivoranscellwalla-glycur-
onosylceramides presented by CD1d molecules.
Combined with the natural liver tropism of NKT cells,
the accumulation of N. aromaticivorans in the liver
likely explains the liver specificity of destructive
responses. Once established, liver disease could
be adoptively transferred by T cells independently
ofNKTcells andmicrobes, illustrating the importance
of early microbial activation of NKT cells in the initia-
tion of autonomous, organ-specific autoimmunity.
INTRODUCTION
Innate immunity is suspected to play a key role in various forms
of autoimmunity, but the precise mechanisms involved in acti-
vating and propagating autoreactive T and B cells have remained
obscure (Benoist and Mathis, 2001; Marshak-Rothstein and
Rifkin, 2007). One frequent cause of innate immune activation
is represented by overt or unrecognized bacterial or viral infec-
tions, but revealing microbial involvement and understanding
the cellular and molecular mechanisms leading to autoimmunity
generally remain a challenge.
Recent studies in humans have suggested that PBC, an auto-
immune disease of the liver, was associated with an antibody304 Cell Host & Microbe 3, 304–315, May 2008 ª2008 Elsevier Inc.response to a particular group of alphaproteobacteria. PBC is
a chronic, lethal liver disease characterized by lymphoid infiltra-
tion and destruction of small bile ducts leading to bile extravasa-
tion and subsequent fibrosis (Kaplan and Gershwin, 2005). It is
associated with signature autoantibodies that recognize mito-
chondrial proteins such as the enzyme PDC-E2, and with autor-
eactive T cells responding to mitochondrial enzymes (Ueno et al.,
2007; Van de Water et al., 1988, 1991; Jones et al., 1995). How-
ever, the relationship between antimitochondrial immunity and
liver pathogenesis has remained obscure. Recently, molecular
mimicry between mitochondria and phylogenetically related
alphaproteobacteria such as Novosphingobium aromaticivor-
ans, which express conserved PDC-E2 epitopes, has been
suggested. N. aromaticivorans is a member of the Sphingomo-
nodaceae family of Gram-negative alphaproteobacteria, which
exhibits xenobiotic-metabolizing properties and is found at mu-
cous surfaces and in the feces of humans (Barbeau et al., 1996;
Cavicchioli et al., 1999; Brodie et al., 2007; Pinyakong et al.,
2003; Shi et al., 2001; Selmi et al., 2003). Strikingly, patients
with PBC expressed antibodies against lipoylated enzymes of
N. aromaticivorans but not E. coli (Kaplan, 2004; Padgett et al.,
2005; Selmi et al., 2003).
The cell wall of various strains of Sphingomonas (also called
Novosphingobium or Sphingobium), a well-studied genus of
the Sphingomonodaceae family, is peculiar by its lack of LPS
and by the expression instead of glycosphingolipids such as
a-glucuronosyl- and a-galacturonosyl-ceramides (Kawahara
et al., 2000; Kawahara et al., 1999; Kosako et al., 2000). These
unusual glycolipids load CD1d glycoproteins in the lysosomal
compartment and are specifically recognized by the conserved,
‘‘canonical’’ T cell receptor of mouse and human CD1d-re-
stricted NKT cells (Figure S1 available online), causing reciprocal
activation of NKT cells and dendritic cells and substantial release
of Th1 and Th2 cytokines and chemokines (Kinjo et al., 2005;
Mattner et al., 2005). Thus, NKT cells and CD1d function as a
major innate pathway for the detection of these microbial cell
wall components and promote rapid microbial clearance upon
infection in vivo. NKT cells accumulate in the liver, where they
crawl along sinusoidal endothelial cells, seemingly ‘‘patrolling’’
this vascular space (Ohteki and MacDonald, 1994; Geissmann
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(Kita et al., 2002; Harada et al., 2003). Further, increased expres-
sion of CD1d was observed in the liver of PBC patients
(Tsuneyama et al., 1998). Thus, we hypothesized that NKT cell
recognition of N. aromaticivorans in the liver might be involved
in liver pathology in PBC patients.
We report that mouse infection with N. aromaticivorans in-
duced antimitochondrial IgG antibodies and the development
of chronic bile duct lesions and lymphoepithelioid granulomas
similar to PBC, in a CD1d-dependent manner. Once chronic
disease was established, it could be transferred to naive mice
by T cells, independently of CD1d, NKT cells, or microbial infec-
tion, demonstrating the establishment of an autonomous
autoimmune process.
RESULTS
N. aromaticivorans Infection Model
Infection of mice with various strains of the genusSphingomonas
(also termed Novosphingobium and Sphingobium) results in
rapid microbial clearance with usually modest clinical signs of
disease (Kinjo et al., 2005; Mattner et al., 2005). To monitor the
emergence of PBC, a chronic disease with a long latency period,
we inoculated various strains of mice withN. aromaticivorans and
measured, over several months, autoantibodies to mitochondrial
antigens in the serum as well as lymphocyte infiltration and bile
duct lesions in the liver. Common mouse strains, including
C57BL/6, NOD, and SJL, all exhibited chronic antimitochondrial
autoantibodies as well as liver lesions after inoculation of
N. aromaticivorans. Injection of 5 3 107 cfu intravenously at
week 0 and week 2 most consistently induced this chronic dis-
ease in nearly all mice. This protocol was therefore used through-
out these studies, unless otherwise stated. Furthermore, we
focused on the NOD 1101 strain because it exhibited particularly
severe enlargement of the liver with lesions suggestive of PBC.
NOD1101 belongs to a set of NOD subcongenic strains originat-
ing from NOD.c3c4 mice produced by introgressing Insulin-de-
pendent diabetes (Idd) loci Idd3, 10, 17, and 18 from B6 onto
chromosomes 3 and Idd9.1-3 from B10 onto chromosome 4 of
NOD (Lyons et al., 2000; Wicker et al., 1994). NOD.c3c4 mice
do not exhibit diabetes but instead spontaneously develop bile
duct lesions and antimitochondrial autoantibodies (Irie et al.,
2006; Koarada et al., 2004). NOD 1101 is a subcongenic strain
with a restricted B6 chromosomal segment corresponding to
Idd10 and Idd18 on chromosome 3 (Podolin et al., 1998). Al-
though NOD 1101 mice do not exhibit liver lesions and do not
spontaneously develop autoantibody titers, we reasoned that
they might harbor some susceptibility genes for bile duct disease.
N. aromaticivorans Infection Induced Long-Lasting IgG
and IgA Responses against Mammalian
and Microbial PDC-E2
Intravenous inoculation of NOD 1101 with N. aromaticivorans,
but not E. coli, induced an IgG response to PDC-E2, as detected
by an isotype-specific ELISA assay of serum samples
(Figure 1A). The anti-PDC E2 IgG response included IgG2a
(see Figure 2) and also IgG1, IgG2b, and IgG3, whereas little
IgA was detected (data not shown). In contrast, IgA autoanti-
bodies were predominantly detected when N. aromaticivoranswas inoculated orally (Figure 1B). These isotype patterns and
the persistence of the IgG response over several months
(Figure 1C) differed therefore from the transient IgM and IgG3
autoreactive responses, for example, against anti-nuclear anti-
gens, that have been reported after infection with other bacteria
(Fournie et al., 1974; Marshak-Rothstein, 2006; Morrison and
Ryan, 1979; Rowley and Jenkin, 1962).
Western blot analysis demonstrated the presence of a 70 kD
band in mouse liver and two bands of 47 and 50 kD in N. aroma-
ticivorans (Figure 1D) characteristic of PDC-E2 in these different
species (Padgett et al., 2005; Selmi et al., 2003). The antibodies
induced in B6 as well as in NOD 1101 mice recognized both
human and mouse recombinant PDC-E2 (Figures 1E and 1F).
These results are consistent with the molecular mimicry hypoth-
esis, suggesting that the autoantibodies are primarily directed
against epitopes shared by N. aromaticivorans (but not E. coli)
PDC-E2 and its mammalian homologs (Selmi and Gershwin,
2004).
In addition to PDC-E2, and as also described in patients with
PBC, a fraction of mice inoculated with N. aromaticivorans
expressed IgG autoantibodies against an additional mitochon-
drial enzyme, BCKD, and against dsDNA (data not shown).
The Chronic Autoantibody Response Elicited
by N. aromaticivorans Was CD1d Dependent
Due to the lack of LPS, which is replaced by glycosphingolipid
antigens recognized by NKT cells, the major component of
innate immunity to the N. aromaticivorans cell wall resides with
the NKT/CD1d pathway rather than with TLRs (Kinjo et al.,
2005; Mattner et al., 2005; Figure S1). We therefore tested
whether CD1d was required for the development of autoanti-
body responses. Since CD1d is closely linked to the Idd10 locus
of NOD 1101, these experiments were performed on a C57BL/6
background where CD1d/ mice are available. Anti-PDC-E2
IgG titers were drastically reduced in CD1d-deficient compared
to wild-type mice (Figure 2A), suggesting that NKT cell activation
by N. aromaticivorans glycosphingolipids provided essential
help for the anti-PDC E2 IgG response. IgM antibodies, which
can be independent of T cell help, were only modestly decreased
(Figure 2A).
NKT cell activation results in systemic release of Th1 and Th2
cytokines, which in turn can broadly enhance distal components
of the immune response. Alternatively, it was possible that auto-
reactive B cells themselves received help from NKT cells, in a
direct ‘‘cognate’’ manner, through the simultaneous presenta-
tion of N. aromaticivorans glycosphingolipid antigens. To test
a requirement for cognate NKT-B cell interactions, we reconsti-
tuted irradiated BALB/c mice with a mixture of Ighb CD1d+/+, and
Igha CD1d/ BALB/c bone marrows. These mixed bone marrow
chimeras expressed similar numbers of Igha (49.9 ± 6.7)- and
Ighb (52.3 ± 7.7)-positive B cells as determined by FACS analysis
(data not shown). Using allotype-specific reagents, we deter-
mined that IgG2aa anti-PDC E2 antibodies were significantly re-
duced compared with their IgG2ab counterpart when measured
10 days after the second inoculation of N. aromaticivorans
(Figure 2B, upper left panel). The same pattern was observed
20 days after the second inoculation, although differences did
not reach statistical significance (data not shown). In contrast,
both allotypes were equally represented at all time points inCell Host & Microbe 3, 304–315, May 2008 ª2008 Elsevier Inc. 305
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in Mice Infected with N. aromaticivorans
(A and B) Mice were inoculated intravenously or
orally with N. aromaticivorans, E. coli, or PBS (un-
infected) at week 0 and week 2, and serum IgG
and IgA antibodies to recombinant PDC-E2 were
measured by ELISA. Results show average and
SD values for NOD 1101 mice (three to four mice
per group) inoculated with N. aromaticivorans or
E. coli DH5a (5 3 107 cfu intravenously [A] or 1 3
109 cfu orally [B]) and examined at week 10 (left
panel) or week 5 (right panels). Data are represen-
tative of 20 NOD 1101 mice per group examined in
six independent experiments between week 4 and
week 12. Similar results were observed when E.
coli ATCC 25922 was used instead of E. coli
DH5a. Statistical significance was calculated us-
ing a Student’s t test: *p < 0.05 and **p < 0.01. Er-
ror bars represent the standard error of the mean
for each group.
(C) Long-term persistence of anti-PDC-E2 IgG an-
tibodies after infection. Sera of NOD 1101 mice
(three per group) were analyzed for the presence
of anti-PDC-E2 IgG responses (average and SD)
at weeks 10, 16, and 25 as indicated. Error bars
represent the standard error of the mean for
each group.
(D) Western blot analysis of N. aromaticivorans (N)
or liver (L) lysates using week 5 and week 10 sera
from NOD 1101 mice uninfected (uninf.) or inocu-
lated with N. aromaticivorans (N. aro.) or E. coli
(E.c.), as indicated. Bound antibodies were re-
vealed with mouse IgG-specific secondary antibodies. Note the 47 kDa and 50 kDa bands corresponding to bacterial lipoylated PDC-E2 protein and the cross-
reactivity to a 70 kDa band in liver extracts corresponding to the molecular weight of mammalian PDC-E2. Results were based on pools of five sera and confirmed
in five independent experiments.
(E) Western blot analysis of sera from uninfected or N. aromaticivorans-infected mice against recombinant PDC-E2. Control (rightmost lane) shows the reactivity
of a monoclonal antibody raised against human PDC-E2 (Migliaccio et al., 1998).
(F) Presence of antibodies against mouse or human recombinant PDC-E2 in sera of individual B6 and NOD 1101 mice infected with N. aromaticivorans (week 7),
as detected by western blot (serum dilution 1:500).control chimeras where the two bone marrows expressed CD1d
(Figure 2B, upper right panel). By examining IgM production with
a similar allotype-specific ELISA assay, we determined that IgM
autoantibody production did not require CD1d expression by the
secreting B cell (Figure 2B, lower panels). Collectively, and
consistent with the well-established helper function of NKT cells
(Van Kaer, 2004), these results suggested that IgG2a but not IgM
responses depended on NKT cell activation, including cognate
interactions between NKT cells and autoantibody-secreting B
cells, likely mediated through presentation of microbial glyco-
sphingolipid antigens.
Chronic Liver Inflammation Induced
by N. aromaticivorans
Like other mouse strains (Kinjo et al., 2005; Mattner et al., 2005),
NOD 1101 mice cleared most of the bacterial load within a week
after infection withN. aromaticivorans as judged by CFU analysis
of different tissues (data not shown). Further analysis with 16S
RNA PCR showed that all tissues, including the liver, were neg-
ative by 8 weeks postinfection (see Figures 6C and 6D). These
mice, however, progressively developed a massive enlargement
of the liver, nearly doubling the organ weight over the course of
10 months (Figure 3A). Other strains, such as SJL, NOD, or B6
(Figure 5A and data not shown) also presented a significant,306 Cell Host & Microbe 3, 304–315, May 2008 ª2008 Elsevier Inc.albeit less important liver enlargement of about 30% over unin-
fected controls. The spleen became enlarged (Figure 3A) due
to lymphocyte accumulation as well as vascular congestion
(data not shown). Further, NOD 1101 mice infected at 6 weeks
of age failed to thrive and exhibited a lower bodyweight (22.4 ±
8.2 g [n = 5] versus 28.4 ± 3.3 g [n = 5] for uninfected littermates,
p < 0.05) at 6 months of age.
Histologic examination of the enlarged livers revealed massive
portal inflammation with lymphocyte infiltration and granulomas.
In contrast with uninfected littermate controls (Figure 3B), prom-
inent infiltrations of bile ducts (Figure 3C), destruction of biliary
epithelial cells with severe bile duct damage (Figures 3C and
3D), and formation of granulomas (Figure 3E) were observed.
In some fields, the lymphoid infiltration was so dense that bile
duct tissue could not be identified, a finding that was interpreted
as a sign of bile duct loss. Lesions of venulitis were also common
(Figure 3F). A similar lymphoid infiltration was found in common
mouse strains such as SJL, NOD, and C57BL/6 mice, but con-
sistent with their more modest hepatomegaly, these strains
seemed to express less severe lymphoid infiltration, although
there was some variation depending on the experiments (Figure 5
and data not shown). Severe fibrosis as seen in human PBC was
not detected in any of the mouse strains examined. The infiltrates
in the portal area were composed of a mixed lympho-monocytic
Cell Host & Microbe
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(Figure 3G and data not shown), the presence of which is used
as diagnostic marker to distinguish PBC from autoimmune hep-
atitis in humans (Scheuer, 1998; Terasaki et al., 1993). Biliary
lesions were accompanied by a persistent upregulation of
Figure 2. Anti-PDC-E2 IgG Autoantibodies Are CD1d Dependent
(A) Wild-type and CD1d-deficient B6 mice (ten per group) were inoculated with
N. aromaticivorans at week 0 and week 2, and a-PDC-E2 IgG and IgM re-
sponses were determined at week 6 in sera diluted as indicated. A cohort of
uninfected B6 mice was also analyzed as negative control. Statistical signifi-
cance was calculated using a Student’s t test. A similar result was obtained
in another experiment using five mice per group.
(B) Irradiated mice reconstituted with a 1:1 mixture of CD1d-deficient Igha and
CD1d-sufficient Ighb bone marrow cells were infected with N. aromaticivorans
at day 0 and day 14. At day 24, the IgG2a and IgM autoantibodies against
PDC-E2 were measured using Igh allotype-specific antibodies to assign their
origin to wild-type or CD1d-deficient B cells. Based on FACS staining of B cells
for CD1d and for IgMa versus IgMa, the chimeras were equivalently reconsti-
tuted by the two bone marrows (51 ± 5.8 IgMa versus 54.1 ± 9.2 IgMb and
49.9 ± 6.7 CD1d+ versus 52.3 ± 7.7 CD1d). Statistical significance was
calculated using a Linear-Mixed-Effect Model.MHC II on bile duct epithelial cells as well as Kupffer cells, endo-
thelial cells, and inflammatory cells (Figure 3H).
To evaluate the specificity of these chronic lesions, we exam-
ined the livers of mice inoculated with E. coli or Salmonella. We
used a scoring system from 1 to 4 to grade from benign to severe
the lesions of portal inflammation, bile duct damage, granuloma
formation, and parenchymal inflammation, as described in the
Experimental Procedures. While transient inflammation could
be detected early after microbial inoculation, as indicated by ag-
gregates of lymphoid and mononuclear cells in the lobular areas
or around the periphery of central veins and by hepatocyte necro-
sis, they resolved within a few weeks, contrasting with the chronic
disease afterN. aromaticivorans infection (Figures 4A and 4B and
data not shown). Similar features of transient inflammation have
been reported after injection of LPS or a-GalCer alone (Biburger
and Tiegs, 2005; Nakagawa et al., 2001; Osman et al., 2000).
Analysis of thyroids, kidneys, joints, and intestines revealed no
chronic inflammation in N. aromaticivorans-infected NOD 1101
mice (data not shown), further supporting the liver specificity of
the inflammation process.
Chronic Liver Inflammation Depended
on CD1d and NKT Cells
To test whether NKT cells were required for chronic liver inflam-
mation, B6 CD1d+/ and B6 CD1d/ littermates were infected
with N. aromaticivorans. Both liver weight increase and histolog-
ical lesions depended on CD1d (Figures 5A and 5B). Similar
results were obtained with CD1d+/ and CD1d/ mice on
a NOD background (data not shown). Further, B6.Va14 trans-
genic mice, which overexpress NKT cells, exhibited more severe
histological lesions as well as higher anti-PDC E2 IgG titers than
wild-type B6 mice (Figure 5C and data not shown).
Early but Not Late Antibiotic Treatment Prevented
Chronic Liver Inflammation and Autoantibodies
Chronic liver inflammation and autoantibody production could
reflect ongoing responses to persistent microbial infection or,
alternatively, represent an immunopathological process evolving
autonomously after the initial microbial encounter. We treated
one group of mice with a combination of ampicillin and strepto-
mycin between week 4 and 8 (Figure 6A) and another group
between week 12 and 16 (Figure 6B). Whereas early treatment
abrogated the course of liver disease and the long-term persis-
tence of autoantibodies, late treatment failed to significantly
ameliorate disease. Consistent with these results, low bacterial
copy numbers could be detected by N. aromaticivorans-specific
16S rRNA PCR mainly in liver, but also in gall bladder, gut, and
kidney at week 3 (Figure 6C) and up to 8 weeks after infection
for the liver (Figure 6D). Although the PCR may amplify other
strains in the family of Sphingomonadaceae, the low levels
detected were well above background as measured in unin-
fected mice. Collectively, these results suggest that microbial
persistence at low copy numbers during the first 4–8 weeks
postinfection is required for the late, sterile phase of chronic liver
inflammation.
T Cell Transfer of Liver Disease
The presence of autoantibodies and the evolution toward
chronic liver inflammation in the absence of long-term microbialCell Host & Microbe 3, 304–315, May 2008 ª2008 Elsevier Inc. 307
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N. aromaticivorans
(A) Progressive increase in liver and spleen weight
of NOD 1101 mice at indicated times after N.
aromaticivorans infection. The results are repre-
sentative of two independent experiments. Statis-
tical significance was calculated using a Student’s
t test.
(B) Liver sections from an uninfected 7-month-old
NOD 1101 mouse. Left panel (53), right panel
(203), and inset show integrity of bile duct epithe-
lium.
(C) Portal inflammation (left panel, 203) with bile
duct damage (right panel, 1003) in a 7-month-old
NOD 1101 infected with N. aromaticivorans at the
age of 1 month.
(D) Portal inflammation and bile duct damage in
a 4-month-old (left panel, 203) and 10-month-old
(right panel, 203) NOD 1101 mouse infected
with N. aromaticivorans at the age of 1 month. In
the right panel, note bile duct damage of different
intensity (white arrow, bile duct damage with
a score of 1; black arrow, bile duct damage with
a score of 4).
(E) Granuloma with epithelioid cell formation
around veins (left panel) and bile ducts (right panel)
in NOD1101 mice at 1.5 months (left panel) and 10
months (right panel) postinfection (203). A dam-
aged bile duct is highlighted by the arrow in the
right panel.
(F) Venulitis (left panel 103, enlarged 403 on the
right panel) in a 3-month-old NOD1101 mouse
infected with N. aromaticivorans at the age of 1
month. Note that the inflammatory infiltrate dis-
rupts the vessel wall and that bile ducts cannot
be identified on this section.
(G) Presence of plasma cells (left panel, 3-month-
old B6) and eosinophils (right panel, 10-month-old
NOD 1101) (203).
(H) Broad expression of MHC II in a B6 mouse at
week 18 after infection (left panel, 103). Higher
magnification shows prominent MHC II expression
on bile duct epithelial cells (right panel, 1003);
right two panels show the isotype control stain-
ings.persistence suggested the possibility of an autoimmune origin to
the liver disease. We therefore transferred 2 3 107 splenocytes
or 5 3 106 liver lymphocytes collected at week 12 postinfection
into irradiated (900 Rads) NOD 1101 recipients. Typical liver dis-
ease developed within 4–6 weeks after transfer of lymphocytes
from infected but not from control, uninfected donors (Figures
7A and 7B). Anti-PDC-E2 antibodies were observed as well
(data not shown). As expected from the negative PCR for
N. aromaticivorans after 8 weeks (Figure 6D), transfer of disease
was not modified by the administration of antibiotics to the host
and/or recipient (data not shown). To test the role of NKT cells in
the transfer of disease, we established a similar transfer system
in the B6 background where CD1d-deficient mice are available.
Although less severe than in the NOD 1101 background, liver
lesions clearly developed in B6.scid recipients of spleen cells
collected at week 12 postinfection in CD1d+/ mice but not
CD1d/ mice, confirming the key role of NKT cells in disease
(Figure 7C). However, disease transfer did not require NKT cells,
as the lesions developed normally in recipients of splenocytes308 Cell Host & Microbe 3, 304–315, May 2008 ª2008 Elsevier Inc.depleted of NKT cells by CD1d-aGC tetramers and MACS.
Depletion of CD4 and CD8 T cells, in contrast, abolished the
transfer of disease (Figure 7C). Further, liver disease could be
induced by T cell transfer into CD1d-deficient as well as CD1d-
sufficient recipients (Figure 7D). Collectively, these results imply
that NKT cells and CD1d are important to initiate the disease
process but that the autoimmune effectors of liver damage are
conventional T cells.
DISCUSSION
A role of N. aromaticivorans or related alphaproteobacteria in
human PBC was recently suggested based on their phylogenetic
relationship with mitochondria, the target organ of PBC patients,
particularly the conserved antibody epitope expressed by the
enzyme PDC E2 (Kaplan, 2004; Padgett et al., 2005; Selmi
et al., 2003). In the current study, we hypothesized that NKT cells,
a specialized lymphocyte population that is enriched in the liver
might contribute to the pathogenesis of PBC. NKT cells were
Cell Host & Microbe
Liver Autoimmunity Triggered by NKT CellsFigure 4. Chronic Liver Disease Is Specific to N. aromaticivorans
(A) Representative liver sections (103 magnification) of NOD 1101 mice infected with N. aromaticivorans (left panel), E. coli (middle panel), and Salmonella
(right panel) 10 months earlier. Note in the left panel the severe portal infiltration with bile duct damage (inset 1, 1003) and moderate fibrosis (inset 2, 1003) after
N. aromaticivorans infection, contrasting with the integrity of livers infected with E. coli or Salmonella.
(B) Histopathological scores of individual livers at 6 weeks and 6 months postinfection. Statistical significance was calculated using a Mann-Whitney test based
on exact p value computations to account for ties. Results are representative of two independent experiments. Mice were infected with 53 107N. aromaticivorans
(filled black squares), 5 3 107 E. coli (filled gray squares), and 5 3 104 Salmonella (filled gray circles) cfus, and histopathological scores were analyzed at the
indicated time points compared to uninfected control mice (empty black squares).shown to specifically recognize the cell wall glycosphingolipids
of various bacterial strains from the genus Sphingomonas, which
includes N. aromaticivorans, through their semi-invariant CD1d-
restricted TCR. By inoculating N. aromaticivorans to mice, we
established a model of liver disease resembling PBC and we
further demonstrated the role of NKT cells in initiating a liver-
specific autoimmune process mediated by T cells as well as in
helping the production of signature anti-PDC E2 antibodies.
Figure 5. Liver Disease Is Dependent on
NKT Cells
(A) Liver weights of CD1d+/ and CD1d/ B6
littermates at indicated time points after infection
with N. aromaticivorans. Statistical significance
was calculated using a Student’s t test.
(B) Histopathological score of liver and bile duct
lesions of wild-type and CD1d-deficient B6 litter-
mates 4 months after N. aromaticivorans infection.
Statistical significance was calculated using a
Mann-Whitney test.
(C) Increased liver pathology inN. aromaticivorans-
infected B6.Va14 transgenic compared with
wild-type B6 mice. Analysis was performed 2
months after infection, and statistical significance
was calculated using a Mann-Whitney test.Cell Host & Microbe 3, 304–315, May 2008 ª2008 Elsevier Inc. 309
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(A and B) Infected NOD 1101 mice inoculated with N. aromaticivorans at week 0 and week 2 were treated with 2 mg/ml Ampicillin and 20 mg/ml Streptomycin
in drinking water between weeks 4 and 8 (A) or between weeks 12 and 16 (B). Panels show liver histopathological score for portal inflammation and bile duct
damage and serum anti-PDC-E2 antibodies for individual mice at week 20. Groups include uninfected, infected, and infected/antibiotic-treated mice as
indicated. Statistical significance was calculated using a Mann-Whitney test (liver lesions) and a Student’s t test (antibody response). Error bars represent the
standard error of the mean for each group.
(C) N. aromaticivorans 16S rRNA qPCR in tissues of NOD 1101 mice inoculated at week 0 and week 2 and analyzed at week 3. Average and SD of bacterial copies
measured in three individual mice. Error bars represent the standard error of the mean for each group.
(D) N. aromaticivorans 16S rRNA qPCR in livers of individual NOD 1101 mice inoculated at week 0 and week 2 and analyzed at various time points as indicated.Inoculation of N. aromaticivorans, whether intravenously or
orally, consistently resulted in the development of chronic liver
disease with liver hypertrophy and massive lymphocytic infitra-
tion in common strains of mice. Congestive splenomegaly also
developed, possibly as an indirect consequence of liver hyper-
trophy. Key diagnostic elements of PBC were recorded, partic-
ularly in the NOD 1101 strain, including the striking infiltration
of small bile ducts, their expression of MHC class II molecules,
the formation of lympho-epithelioid granulomas, and the pres-
ence of eosinophils. Other lesions such as venulitis, hepatocyte
lesions, and plasma cell expansion have been more often re-
ported in autoimmune hepatitis, a poorly understood disease
entity, or in graft versus host reactions (Czaja, 1994; Scheuer,
1998; Sherlock, 1998; Mieli-Vergani and Vergani, 2004). A nota-
ble difference with human PBC, however, was the absence of
marked fibrosis in the mouse system. Fibrosis, which is thought
to be a tissue reaction to the bile extravasation associated with
bile duct epithelium destruction, may involve Th2 cytokines that
are suppressed in the mouse system, particularly in the NOD
background (Delovitch and Singh, 1997). Indeed, exposure
to N. aromaticivorans induced relatively little Th2 cytokines310 Cell Host & Microbe 3, 304–315, May 2008 ª2008 Elsevier Inc.from mouse NKT cells in vitro compared with purified glyco-
sphingolipid antigens (data not shown). Collectively, therefore,
our findings support the notion that diverse susceptibility or re-
sistance genes influence the final expression of the N. aromati-
civorans-induced liver disease. Future studies will explore the
genetics of N. aromaticivorans-induced liver disease in greater
detail.
Importantly, liver disease was transferred upon injection of
conventional T cells collected from the liver or the spleen of
chronically diseased mice, into naive irradiated or SCID synge-
neic recipients. While T cell responses to PDC-E2 have been
previously demonstrated in PBC patients, consistent with
a breakdown of tolerance to this antigen, their pathogenic nature
remains uncertain. In contrast, the transfer experiment provided
definitive proof of T cell-mediated autoimmunity as a cause of
disease, although the autoantigens recognized by disease-
causing T cells in this model remain to be elucidated. It is note-
worthy that another bile duct disease reminiscent of biliary atre-
sia, which develops in some pediatric patients, was recently ob-
served in mice after rotavirus infection and could be transferred
with T cells (Mack et al., 2006).
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autoantibodies against PDC-E2, the serological signature of
PBC, were observed in all mouse strains examined. We detected
anti-dsDNA as well, although at relatively low titer and frequency
compared with mouse models of lupus such as NZBxNZW or
MRL (data not shown). Nevertheless, it is worth noting that
anti-DNA antibodies have also been reported in a fraction of
PBC patients and that multiple forms of autoimmunity, including
lupus, type I diabetes, Sjogren syndrome, or celiac disease can
be found among relatives of some PBC patients (Kaplan and
Gershwin, 2005).
NKT cells specifically recognize N. aromaticivorans cell wall
glycosphingolipids and, in the absence of LPS to activate
TLRs, dominate the innate immune response. While they sig-
nificantly accelerate the clearance of N. aromaticivorans, they
are not required for recovery. Therefore, their activation upon mi-
crobial encounter may be deleterious for the host, providing in-
Figure 7. N. aromaticivorans-Induced Liver
Disease Is Transferred by T Cells
(A) Liver sections 6 weeks after syngeneic transfer
into adult irradiated recipients of 5 3 107 spleno-
cytes from NOD 1101 donors uninfected or in-
fected 12 weeks before with N. aromaticivorans.
Note the presence of diffuse lesions in the recipi-
ents of splenocytes from infected donors at 103
magnification and the bile duct infiltration at
1003 magnification.
(B) Histopathological scores of liver lesions after
transfer of 2 3 107 splenocytes. Statistical signifi-
cance was calculated using a Mann-Whitney test.
Similar results were obtained after transfer of 5 3
106 liver MNCs (data not shown). These results
are representative of two independent experi-
ments with similar results.
(C) Transfer of liver disease by 23 107 splenocytes
of N. aromaticivorans -infected B6.CD1d+/ but
not B6.CD1d/ mice into B6.scid recipients.
Depletion of CD4+ and CD8+ T cells, but not
NKT cells, prevented disease transfer. Results of
two independent experiments have been com-
bined, and statistical significance of the differ-
ences in histopathological scores was calculated
using a Mann-Whitney test.
(D)Transferofsplenocytes fromN.aromaticivorans-
infected B6 into irradiated B6.CD1d+/ and
B6.CD1d/ recipients shows that disease transfer
does not require CD1d expression by the host.
nate signals that contribute to the break-
down of tolerance and unleash
autoimmune effector cells. Indeed,
CD1d-deficient mice were largely pro-
tected against manifestations of autoim-
munity including humoral and cellular re-
sponses. Mixed chimera experiments
further suggested that NKT cells could di-
rectly help CD1d-expressing but not
CD1d-deficient anti-PDC-E2 B cells to
switch to IgG2a. This finding would imply
that B cells recognizing PDC-E2 can cap-
ture some glycosphingolipid ligand, pre-
sumably attached to the same microbial cell wall fragment to
which the enzyme is appended by a lipoyl moiety, for loading
onto CD1d in the lysosomal compartment and presentation at
the cell surface. Such B cells would then receive NKT cell help,
including CD40L and cytokines to induce isotype switch and per-
haps somatic hypermutation as well. Consistent with this sce-
nario, CD1d-deficient B cells mainly produced the T helper-inde-
pendent IgM and IgG3 isotypes.
While NKT cells were clearly required to initiate the cellular and
humoral components of disease, they were not necessary at the
late chronic phase of the immunopathological process, as
evidenced by disease transfer in the absence of NKT cells in
the cellular inoculum or in the absence of CD1d in the recipients.
This finding supports the notion that NKT cells mainly contribute
to the innate phase of the response by provoking the breakdown
of tolerance. The expansion of PDC-E2-specific B cells might in
turn contribute to the expansion of PDC-E2-specific T cellsCell Host & Microbe 3, 304–315, May 2008 ª2008 Elsevier Inc. 311
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and subsequent presentation of peptide/MHC complexes (Lin
et al., 1991). Other autoreactive B and T cells might be subse-
quently expanded through a similar process spreading to phys-
ically associated or proximal autoantigens (Lehmann et al., 1992;
Vanderlugt et al., 1998). In that respect, it is notable that very low
levels of N. aromaticivorans, as detected by PCR, persisted for
several weeks after the bulk of the original microbial inoculum
was cleared, perhaps providing continuous fuel for NKT cell
activation, and that antibiotic treatment during that period pre-
vented the evolution of chronic cellular and humoral autoimmu-
nity. Consistent with a requirement for prolonged exposure to
microbial elements, injection of heat-killed N. aromaticivorans in-
duced only transient anti-PDC-E2 response and liver lesions
(data not shown). In that context, the preferential activation of
NKT cells in the liver, where NKT cells are abundant, crawling
along sinusoid endothelial cells and where N. aromaticivorans
also accumulates, may explain the biased autoreactivity toward
autoantigens exposed in the liver environment and, ultimately,
the severe organ-specific manifestations of N. aromaticivorans
infection. The nature of these pathogenic autoantigens, how-
ever, remains to be elucidated.
N. aromaticivorans, like many other strains of the genus
Sphingomonas in the Sphingomonadaceae family, is an ubiqui-
tous organism found in various marine, terrestrial, and aerosol
environments (Barbeau et al., 1996; Cavicchioli et al., 1999; Shi
et al., 2001; Brodie et al., 2007). It is also detected by PCR in
human feces (Selmi et al., 2003). While this genus only occasion-
ally causes severe infection in immunodeficient individuals
(Al-Anazi et al., 2008; Ensminger et al., 2006; Charity and Foukas,
2005), it is likely that most individuals are chronically exposed
to these microbial organisms. Our findings raise the question
of whether and how aberrant activation of NKT cells might
occur in response to this or related organism in the liver of
some genetically predisposed patients, ultimately causing or
promoting primary biliary cirrhosis. The ability of some strains
such as N. aromaticivorans to degrade xenobiotic and steroid
aromatic compounds may be an important factor (Pinyakong
et al., 2003; Shi et al., 2001). Chemical xenobiotics might modify
PDC-E2 or other self antigens and lead to loss of tolerance in in-
dividuals predisposed to autoimmunity (Gluud, 2002; Amano
et al., 2005; Ju, 2005). For example, guinea pigs injected with
6-bromohexanoate developed cholangitis and antimitochondrial
antibodies (Leung et al., 2007). Environmental factors have been
suggested to induce or exacerbate PBC (Triger, 1980; Uibo and
Salupere, 1999; Watson et al., 1995), including urinary tract
infections, tobacco, reproductive hormones, and exposure to
nail polish. Other studies found increased prevalence of PBC
near toxic waste sites (Ala et al., 2006). Based on the mouse in-
fection studies presented here and the previous studies showing
crossreactivity of anti-PDC-E2 autoantibodies to N. aromatici-
vorans in humans with PBC, we propose the following conclu-
sions. First, a breakdown of tolerance is a critical component
of PBC, as shown by the appearance of autoantibodies against
PDC-E2 and the ability of T cells to transfer liver disease. These
features also characterize other mouse models of PBC, including
the NODc3c4 strain, IL2Ra-deficient mice, and mice transgeni-
cally expressing a dominant-negative form of the TGFb receptor
II (Irie et al., 2006; Koarada et al., 2004; Aoki et al., 2006; Waka-312 Cell Host & Microbe 3, 304–315, May 2008 ª2008 Elsevier Inc.bayashi et al., 2006; Oertelt et al., 2006). Second, by virtue of
coexpressing potent NKT ligands and 2-oxo-dehydrogenase
enzymes with high degree of homology to their mitochondrial
counterparts, N. aromaticivorans has a unique ability to induce
PBC. Thus, the present study provides an experimental demon-
stration and a mechanistic dissection of the role of NKT cells in
the transition from early microbially driven immune responses
to a stage of autonomous, microbial-independent, T and B cell
autoimmunity. These findings warrant further studies on the
role of the commensal flora, environmental microbes, and
CD1d-restricted NKT cells in human PBC and its different exper-
imental models. We do not suggest thatN. aromaticivorans is the
only possible cause of PBC, but rather that it presents a model




B6, Balb/c (Igha and Ighb), Balb/c.CD1d/, NOD, SJL, and B6.scid mice were
purchased from Jackson laboratories. B6.CD1d/ mice and the NOD
congenic strain 1101 (Podolin et al., 1998) was maintained in our laboratories.
The NOD 1101 strain (NOD.B6 Idd10/18R2) was obtained from Taconic (Ger-
mantown, NY) and is available through the Emerging Models program as Line
1101 (for a description of the introgressed interval, see http://t1dbase.org/
cgi-bin/dispatcher.cgi/DrawStrains/display?taconic_line=1101). The NOD
1101 strain was found during the course of this study to harbor a 3.19 Mb
B6-derived region on chromosome 18 having a centromeric ‘‘out’’ boundary
at rs6303064 (19.74 Mb in Ensembl, NCBI m36) and a telomeric ‘‘out’’ bound-
ary at rs13483251 (22.93 Mb). This region on chromosome 18 is not responsi-
ble for the protection from diabetes observed in NOD 1101 mice (Podolin et al.,
1998). All mice were MuLV free and were raised in a specific pathogen-free
environment at the University of Chicago according to the Institutional Animal
Care and Use Committee guidelines.
Bacterial Strains, Live Infection Experiments,
and Treatment with Antibiotics
N. aromaticivorans (ATCC 700278), Salmonella typhimurium R71, and E. coli
(DH5a and ATCC 25922) were grown overnight in Mueller Hinton broth, diluted
in fresh medium, grown for 8 hr at 37C to an OD of 0.5 at 600 nm, washed, and
diluted in PBS. Bacterial suspension (100 ml) containing 5 3 107 N. aromatici-
vorans, 5 3 107 E. coli or 5 3 104 Salmonella cfus was injected intravenously
into 4- to 20-week-old mice on day 0 and on day 14. Antibiotics were
administered in drinking water containing 2 mg/ml Ampicillin and 20 mg/ml
Streptomycin.
Anti-PDC-E2 ELISA
Serum antibodies against the conserved microbial and mammalian PDC-E2
epitope (Padgett et al., 2005) were detected by ELISA against human recombi-
nant PDC-E2 according to the manufacturer’s instructions (BioQuant, San
Diego, CA), with biotin-conjugated anti-mouse IgG, IgG1, IgG2a, IgG2b,
IgG3, IgA, and IgM antibodies obtained from eBioscience (San Diego, CA) or
from Southern Biotech (Birmingham, AL).
Immunoreactivity to Mitochondria and Epitope Specificity Analysis
Serum antibodies to the major mitochondrial antigens PDC-E2, BCOADC-E2,
and OGDC-E2 were detected by immunoblotting (with 1:200 and 1:500 serum
dilutions) against 20 mg recombinant protein resolved by SDS-PAGE and
developed by chemiluminescence as described previously (Padgett et al.,
2005; Selmi et al., 2003). A control anti-PDC-E2 mAb (Padgett et al., 2005)
was used as a positive control. The specific epitopes recognized were further
determined by immunoblotting against the outer lipoyl domain, inner lipoyl do-
main, E1/E3 binding site, and the catalytic domain of PDC-E2 resolved on 10%
SDS-PAGE.
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Antigens
Protein lysates from total liver andN.aromaticivoranswere preparedusinga TNE
(50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 5 mM EDTA) lysis buffer containing
1 mM Na3VO4, 1 mM DTT, 5 mg/ml each leupeptin and aprotinin, and 0.5 mM
PMSF. Lysate (70mg) was separated on a 10% SDS page gel and electroblotted
to a Polyvinylidene fluoride (PVDF) membrane. Membranes were immunoblot-
ted overnight with 1:100–1:500 dilutions of mouse sera in 5% milk powder
followed by a 2 hr incubation with a 1:500 dilution of HRP-conjugated goat-
anti-mouse Fab0 peroxidase IgG (Jackson Immunoresearch, West Grove, PA)
and detection with ECL Plus (Amersham Pharmacia Biotech, Pittsburgh, PA).
Mixed Bone Marrow Radiation Chimeras
A mixture of 53 106 IghbCD1d+/+ and 53 106 IghaCD1d/ bone marrow cells
was injected intravenously into 7- to 12-week-old Ighb CD1d+/+ mice (all on
a Balb/c background) that had been 900 Rad irradiated with a cesium source
(Gammacell 40, Nordion International Inc. Ontario, Canada) 1 day before. As
controls, mixed bone marrow chimeras made with Ighb CD1d+/+ and Igha
CD1d+/+ bone marrow cells were prepared. The B cell reconstitution of the
mixed bone marrow chimeras was determined 6–8 weeks after bone marrow
injection by FACS analysis of blood samples using anti-IgMa, anti-IgMb, and
anti-CD1d antibodies. The chimeras were intravenously injected with 5 3
107 N. aromaticivorans at days 0 and 14, and sera were collected at days 24
and 34. Serum anti-PDC-E2 ELISAs were revealed with the biotinylated,
allotype-specific antibodies goat anti-mouse IgG2aa, IgG2ab, IgMa, and
IgMb (BD Biosciences, San Diego, CA).
N. aromaticivorans-Specific PCR
Total DNA was extracted from different organs using the DNeasy tissue extrac-
tion kit (QIAGEN, Valencia, CA). The following primers were used for detection
of N. aromaticivorans: forward 50-TCCGAGTGTAGAGGTGAAAT-30, reverse
50-CGTCAATACTTGTCCAGTCA-30; for control HPRT: forward 50-ACCTCTCG
AAGTGTTGGATA-30, reverse 50-CAACAACAAACTTGTCTGGA-30. Quantita-
tive PCR (qPCR) was performed with 20 ml Brilliant SYBR Green QPCR Master
Mix (Stratagene, La Jolla, CA), 1 ml (50 ng) of DNA, 0.5 ml (of 100 nM stock) of
each of the forward and reverse primers, and 28 ml of ddH20, using the Mx4000
multiplex quantitative PCR instrument (Stratagene, La Jolla, CA) following the
Brilliant SYBR Green QPCR Master Mix manual (Stratagene, La Jolla, CA).
N. aromaticivorans copy number per 10 mg of tissue was calculated by refer-
ence to a standard of pure N. aromaticivorans DNA.
Flow Cytometry
CD1d-lipid tetramers were prepared as described (Benlagha et al., 2000).
Anti-B220, -CD19, -CD4, -CD8, -CD3, -TCRb, -IgM, -IgD, -CD1d, IgMa,
IgMb, and -CD69 antibodies were purchased from PharMingen. Cells were
analyzed on a LSR II (BD Biosciences, San Diego, CA) with FlowJo software
or a FACSCalibur (BD Biosciences) machine with CellQuest software.
Cell Transfer Experiments
Splenocytes (23 107) or liver MNCs (53 106) of diseased (week 12 postinfec-
tion) B6.CD1+/, B6.CD1/, or NOD 1101 mice were injected i.v. into synge-
neic adult B6.scid or irradiated NOD 1101 recipients, respectively. Depletion of
CD4+ and CD8+ T cells, CD19+ B cells, or CD1d-aGalCer tetramer+ NKT cells
was accomplished with the AutoMACs system (Miltenyi Biotec, Germany) us-
ing anti-PE or anti-APC beads and following the manufacturer’s instructions
with purity control by FACS.
Histology
Liver tissue was fixed in 10% buffered formalin, embedded in paraffin, and cut
into 5 mm sections. Liver sections were deparaffinized, stained with hematox-
ylin and eosin by the University of Chicago Pathology and Histology Research
laboratories, and evaluated microscopically in double-blind studies for leuko-
cytic and lymphocytic infiltration. Liver lesions were classified in four different
categories (portal inflammation, bile duct damage, granuloma formation, and
parenchymal inflammation) and scored by examining 5 sections separated
by 25 mM. Portal and parenchymal inflammation were scored using the follow-
ing scale: 0 = no inflammation, 1 = sparse mononuclear cell infiltrates, 2 = mod-
erate inflammation, 3 = intense inflammation, 4 = intense inflammation andspillover into the periportal parenchyma. The score was based on the most
severe infiltration observed in the majority of portal fields or parenchymal
areas. Granuloma formation was scored based on the number of granulomas
per section: 0 = none, 1 = rare scattered portal and lobular granulomas (<5); 2,
5 to 10 granulomas; 3, 10 to 20 granulomas; 4, more than 20 granulomas. Bile
duct damage was scored as follows: 1, epithelial cell hypertrophy, vacuoliza-
tion, swelling, and flattening could be seen despite the absence of epithelial
cell infiltration by lymphocytes; 2, bile duct damage and small infiltration by
lymphoid cells; 3, severe bile duct damage and infiltration by lymphocytes;
4, altered bile duct morphology accompanied by massive infiltration by lym-
phocytes. The infiltration of portal fields was sometimes so dense that it was
impossible to identify bile duct epithelium. This could possibly reflect bile
duct loss. The bile duct score was based on the most severe lesion observed
in at least five bile ducts in one section.
Immunohistochemistry
Liver sections were embedded in optimal cutting temperature OCT com-
pound (Tissue-Tek, Sakura Finetec, Torrance, CA) and frozen in liquid nitro-
gen. Five-micrometer-thick sections were cut with a cryostat, placed on
3-amino-propyltriethoxysilane-coated slides, and fixed in ice-cold acetone
for 10 min. Slides were incubated in 0.3% H2O2, washed, and blocked
with 10% goat serum in Protein Block (Immunicon, Huntingdon Valley,
PA). The slides were then incubated with rat anti-CD3 1:100 (BD Biosci-
ences) in a humidity chamber, washed with PBS, and incubated with biotiny-
lated goat anti-rat (Jackson ImmunoResearch Laboratories, West Grove,
PA). After washing, the slides were incubated with ABC (Vector Laboratories,
Burlingame, CA), washed, and incubated with AEC solution (Scytek, Engle-
wood, CO). The slides were rinsed and counterstained with aqueous hema-
toxylin blue. Cell subsets were detected with biotin-conjugated antibodies
(CD4, CD8, B220, and CD11c cells from eBioSciences; CD11b from Abcam,
Cambridge, MA; F4/80 from Serotec, Raleigh, NC). MHC II staining was de-
tected with anti- I-A/I-E 2G9 from BD PharMingen). The slides were then
incubated with ABC (Vector Laboratories), washed, incubated with diamino-
benzidine (DakoCytomation, Dako, Denmark), and counterstained with
hematoxylin blue.
Statistical Analyses
The tailed Student’s t test was used to calculate statistical significance
between groups. For Figure 2B, a Linear-Mixed-Effect Model was used.
Statistical comparisons of liver histopathological scores were performed using
the Mann-Whitney test.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures and
one supplemental figure and can be found with this article online at http://
www.cellhostandmicrobe.com/cgi/content/full/3/5/304/DC1/.
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